Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2016</strong><br />
According to market demands<br />
"The Report <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2016</strong><br />
provides information on pricing, market analysis, shares, forecast, and company<br />
profiles for key industry participants. MarketResearchReports.biz"<br />
Global Markets Directs, <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong><br />
<strong>2016</strong>, provides in depth analysis on <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) targeted<br />
pipeline therapeutics.<br />
The report provides comprehensive information on the <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong><br />
(<strong>CGRP</strong>), targeted therapeutics, complete with analysis by indications, stage of development,<br />
mechanism of action (MoA), route of administration (RoA) and molecule type. The report<br />
also covers the descriptive pharmacological action of the therapeutics, its complete research<br />
and development history and latest news and press releases. Additionally, the report<br />
provides an overview of key players involved in <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>)<br />
targeted therapeutics development and features dormant and discontinued projects.<br />
Global Markets Directs report features investigational drugs from across globe covering<br />
over 20 therapy areas and nearly 3,000 indications. The report is built using data and<br />
information sourced from Global Markets Directs proprietary databases,<br />
company/university websites, clinical trial registries, conferences, SEC filings, investor<br />
presentations and featured press releases from company/university sites and industryspecific<br />
third party sources. Drug profiles featured in the report undergoes periodic review<br />
following a stringent set of processes to ensure that all the profiles are updated with the<br />
latest set of information. Additionally, various dynamic tracking processes ensure that the<br />
most recent developments are captured on a real time basis.<br />
The report helps in identifying and tracking emerging players in the market and their<br />
portfolios, enhances decision making capabilities and helps to create effective counter<br />
strategies to gain competitive advantage.<br />
Download Sample copy of this Report at :<br />
http://www.marketresearchreports.biz/sample/sample/726754<br />
Scope<br />
The report provides a snapshot of the global therapeutic landscape for <strong>Calcitonin</strong> <strong>Gene</strong><br />
<strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>)
The report reviews <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) targeted therapeutics under<br />
development by companies and universities/research institutes based on information<br />
derived from company and industryspecific sources<br />
The report covers pipeline products based on various stages of development ranging from<br />
preregistration till discovery and undisclosed stages<br />
The report features descriptive drug profiles for the pipeline products which includes,<br />
product description, descriptive MoA, R&D brief, licensing and collaboration details & other<br />
developmental activities<br />
The report reviews key players involved in <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>)<br />
targeted therapeutics and enlists all their major and minor projects<br />
The report assesses <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) targeted therapeutics based<br />
on mechanism of action (MoA), route of administration (RoA) and molecule type<br />
The report summarizes all the dormant and discontinued pipeline projects<br />
The report reviews latest news and deals related to <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong><br />
(<strong>CGRP</strong>) targeted therapeutics<br />
Reasons to buy<br />
Gain strategically significant competitor information, analysis, and insights to formulate<br />
effective R&D strategies<br />
Identify emerging players with potentially strong product portfolio and create effective<br />
counterstrategies to gain competitive advantage<br />
Identify and understand the targeted therapy areas and indications for <strong>Calcitonin</strong> <strong>Gene</strong><br />
<strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>)<br />
Identify the use of drugs for target identification and drug repurposing<br />
Identify potential new clients or partners in the target demographic<br />
Develop strategic initiatives by understanding the focus areas of leading companies<br />
Plan mergers and acquisitions effectively by identifying key players and its most promising<br />
pipeline therapeutics<br />
Devise corrective measures for pipeline projects by understanding <strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong><br />
<strong>Peptide</strong> (<strong>CGRP</strong>) development landscape<br />
Develop and design inlicensing and outlicensing strategies by identifying prospective<br />
partners with the most attractive projects to enhance and expand business potential and<br />
scope<br />
Browse Latest News at http://www.marketresearchreports.biz/articles<br />
Table of Contents<br />
Table of Contents 2<br />
List of Tables 4<br />
List of Figures 4<br />
Introduction 5<br />
Global Markets Direct Report Coverage 5<br />
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) Overview 6<br />
Therapeutics Development 7<br />
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) Products under Development by Stage of<br />
Development 7<br />
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) Products under Development by Therapy Area 8<br />
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) Products under Development by Indication 9
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) <strong>Pipeline</strong> Products Glance 10<br />
Late Stage Products 10<br />
Early Stage Products 11<br />
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) Products under Development by Companies 12<br />
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) Therapeutics Assessment 14<br />
Assessment by Monotherapy/Combination Products 14<br />
Assessment by Mechanism of Action 15<br />
Assessment by Route of Administration 17<br />
Assessment by Molecule Type 19<br />
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) Companies Involved in Therapeutics<br />
Development 21<br />
Alder Biopharmaceuticals Inc. 21<br />
BCN <strong>Peptide</strong>s, S.A. 22<br />
Boehringer Ingelheim GmbH 23<br />
Eli Lilly and Company 24<br />
BCN <strong>Peptide</strong>s, S.A. 25<br />
Teva Pharmaceutical Industries Ltd. 26<br />
Noxxon Pharma AG 27<br />
<strong>Calcitonin</strong> <strong>Gene</strong> <strong>Related</strong> <strong>Peptide</strong> (<strong>CGRP</strong>) Drug Profiles 28<br />
ALD403 Drug Profile 28<br />
Product Description 28<br />
Mechanism Of Action 28<br />
R&D Progress 28<br />
DD04107 Drug Profile 31<br />
Product Description 31<br />
Mechanism Of Action 31<br />
R&D Progress 31<br />
galcanezumab Drug Profile 32<br />
Product Description 32<br />
Mechanism Of Action 32<br />
R&D Progress 32<br />
NOXL41 Drug Profile 34<br />
Product Description 34<br />
Mechanism Of Action 34<br />
R&D Progress 34<br />
olcegepant Drug Profile 35<br />
Product Description 35<br />
About us<br />
MarketResearchReports.biz is the most comprehensive collection of market research<br />
reports. MarketResearchReports.Biz services are specially designed to save time and money<br />
for our clients. We are a one stop solution for all your research needs, our main offerings<br />
are syndicated research reports, custom research, subscription access and consulting<br />
services. We serve all sizes and types of companies spanning across various industries.<br />
Contact<br />
Mr. Nachiket<br />
State Tower
90 Sate Street, Suite 700<br />
Albany, NY 12207<br />
Tel: +15186212074<br />
Website: http://www.marketresearchreports.biz/<br />
E: sales@marketresearchreports.biz
Change language